TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/9/08 20:55 | 7/1/08 | MEDE | Medecision, Inc. | PA | Tech | SwSv | Computer Programming Services | Great Point Partners LLC | CT | T | P | 1,076 | 6.65 | 0 | 162 | 11 | 1,582 | I | |||||||||||||||
6/30/06 18:07 | 6/28/06 | ISPH | Inspire Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Great Point Partners LLC | CT | T | P | 1,310 | 4.03 | 0 | 325 | 8 | 4,605 | B | |||||||||||||||
1/20/05 17:23 | 1/18/05 | NEOP | Neoprobe Corp | DE | Health | MdEq | Surgical & Medical Instrument | Great Point Partners LLC | CT | T | P | 195 | 0.5816 | 0 | 335 | New | 335 | D | |||||||||||||||
8/25/04 16:20 | 3/12/04 | VLTS | Valentis Inc | DE | Health | BioPrd | Biological Products, (No Diag | Great Point Partners LLC | CT | T | P.am | 577 | 6.01 | 0 | 96 | 9 | 1,163 | I | |||||||||||||||
8/23/04 17:53 | 3/12/04 | VLTS | Valentis Inc | DE | Health | BioPrd | Biological Products, (No Diag | Great Point Partners LLC | CT | T | P.m | 577 | 6.01 | 0 | 96 | 9 | 1,163 | I | |||||||||||||||
6/4/04 18:44 | 2/11/04 | VLTS | Valentis Inc | DE | Health | BioPrd | Biological Products, (No Diag | Great Point Partners LLC | CT | T | P | 120 | 4.99 | 0 | 24 | 2 | 1,061 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |